Bank of America
BNGO icon

Bank of America’s Bionano Genomics BNGO Stock Holding History

Bank of America’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,453
Closed -$12.9K – 5853
2025
Q4 		$12.9K Sell
8,453
-54
-0.6% -$93 ﹤0.01% 6115
2025
Q3 		$14.5K Buy
8,507
+98
+1% +$312 ﹤0.01% 7135
2025
Q2 		$27.6K Buy
8,409
+16
+0.2% +$60 ﹤0.01% 6986
2025
Q1 		$23.4K Buy
8,393
+8,373
+41,865% +$54.8K ﹤0.01% 6929
2024
Q4 		$344 Buy
20
+2
+11% +$34 ﹤0.01% 7473
2024
Q3 		$484 Buy
18
+3
+20% +$93 ﹤0.01% 7387
2024
Q2 		$624 Sell
15
-15
-50% -$824 ﹤0.01% 7313
2024
Q1 		$1.97K Sell
30
-123
-80% -$9.18K ﹤0.01% 7128
2023
Q4 		$17.4K Buy
153
+121
+378% +$12.6K ﹤0.01% 6814
2023
Q3 		$5.83K Sell
32
-27
-46% -$7.07K ﹤0.01% 6961
2023
Q2 		$21.6K Sell
59
-590
-91% -$266K ﹤0.01% 6691
2023
Q1 		$432K Sell
649
-13
-2% -$11.5K ﹤0.01% 5470
2022
Q4 		$580K Buy
662
+272
+70% +$342K ﹤0.01% 5274
2022
Q3 		$428K Sell
390
-11
-3% -$14.5K ﹤0.01% 5517
2022
Q2 		$332K Sell
401
-21
-5% -$21.6K ﹤0.01% 5729
2022
Q1 		$653K Buy
422
+3
+0.7% +$4.05K ﹤0.01% 5622
2021
Q4 		$752K Buy
419
+224
+115% +$599K ﹤0.01% 5532
2021
Q3 		$643K Sell
195
-378
-66% -$1.32M ﹤0.01% 5440
2021
Q2 		$2.52M Buy
573
+566
+8,086% +$2.23M ﹤0.01% 4132
2021
Q1 		$34K Buy
+7
New +$39.5K ﹤0.01% 6750
2020
Q1 		– Hold
0
– – – 6856
2019
Q4 		– Hold
0
– – – 7088
2019
Q3 		– Sell
-1
Closed -$1K – 7258
2019
Q2 		$1K Buy
+1
New +$2.04K ﹤0.01% 7013
2019
Q1 		– Hold
0
– – – 7110
2018
Q4 		– Hold
0
– – – 7113

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bank of America's BNGO Position: Q1 2026 in Review

Bank of America sold out of Bionano Genomics (BNGO) in Q1 2026, closing a stake of 8,453 shares — an estimated $12.9K sold.

Bank of America first reported a position in BNGO in Q2 2019 and held it in 21 quarters. The position peaked at $2.52M in Q2 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

  • Bank of America reported no remaining Bionano Genomics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 8,453 Bionano Genomics shares in Q1 2026, an estimated $12.9K.
  • Bank of America first reported a position in Bionano Genomics in Q2 2019 and held it in 21 quarters.
  • Bank of America's Bionano Genomics position peaked at $2.52M in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.